enVVeno Medical Ended Q2 2023 With $29.8M In Cash, Investments
Portfolio Pulse from Benzinga Newsdesk
enVVeno Medical has reported its Q2 2023 financial results, ending the quarter with $29.8 million in cash and investments.
July 31, 2023 | 9:14 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
enVVeno Medical, listed as NVNO, ended Q2 2023 with $29.8 million in cash and investments.
The news reports on enVVeno Medical's Q2 2023 financial results, specifically its cash and investment holdings. This information is important for investors as it provides insight into the company's financial health. However, without additional context such as the company's burn rate or comparison to previous quarters, it's difficult to predict the impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100